Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc ICOTF


Primary Symbol: T.MSCL Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).


TSX:MSCL - Post by User

Post by shareswapperon Dec 11, 2020 5:07pm
178 Views
Post# 32091035

Lots of Speculation on "Special Meeting" Dec. 30th

Lots of Speculation on "Special Meeting" Dec. 30thJust got my package in the Mail today.  Some Investors are suggesting the "Special Meeting" is to just vote on the new Stock Option Plan.  I highly doubt that as this does not require a "Special Meeting" and could have been handled as part of the AGM.  Also, they are asking for 4X the number of Options to be authorized for distribution to Directors and Managment.  Who would vote positively for that unless they have something BIG to share?  Also they want the options to vest immediately if an "Acceleration Evenet" (change of control) happens ..... No my Friends, there is something "Special" about the "Special Meeting" and it's tied to CEO Jarosz picking up 850,000 shares in late September .....
<< Previous
Bullboard Posts
Next >>